SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-098486
Filing Date
2023-12-26
Accepted
2023-12-26 13:04:18
Documents
1
Period of Report
2023-12-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4076
  Complete submission text file 0001213900-23-098486.txt   5527
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INMED PHARMACEUTICALS INC. SUITE 310 - 815 HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address
HULL ANDREW (Reporting) CIK: 0001818252 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39685 | Film No.: 231512385